<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01523938</url>
  </required_header>
  <id_info>
    <org_study_id>HYPNOC</org_study_id>
    <nct_id>NCT01523938</nct_id>
  </id_info>
  <brief_title>Influence of Perioperative Hypnotherapy on Postoperative Improvement in Cognitive Performance</brief_title>
  <acronym>HYPNOC</acronym>
  <official_title>Influence of Perioperative Hypnotherapy on Postoperative Improvement in Cognitive Performance. A Randomized-controlled Open Clinical Monocentric Interventional Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study examines prospects of hypnotherapy in reducing agitation in patients after cardiac&#xD;
      or spinal column surgery. A particular aim is to point out the effects on postoperative&#xD;
      cognitive outcome. Additional blood and urine tests are conducted (concerning cardiac&#xD;
      stratum).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative cognitive dysfunction at the time of discharge</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative cognitive dysfunction three months after surgery</measure>
    <time_frame>three months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in pre- and postoperative agitation and anxiety</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of pain</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of stress</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of holding time</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of hospital stay</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of Intensive Care Unit stay</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emotional status</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>on day 7 - 30 after surgery</time_frame>
    <description>Planned measures on the seventh postoperative day or on day of hospital discharge (≤ 30 days after surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective evaluation of sleep quality</measure>
    <time_frame>Before surgery</time_frame>
    <description>Insomnia Severity Index (ISI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative assessment of sleep stage</measure>
    <time_frame>the night after surgery;the night before discharge; 3 months after surgery</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Additional blood and urine tests (concerning cardiac stratum)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <description>oxidized Parathyroid hormone and real intact, biologically active Parathyroid hormone&#xD;
Urine: Creatinin, ionized Calcium, Phosphate&#xD;
Calprotectin&#xD;
S100A12&#xD;
Arterial blood: Calcium ionized, Phosphate and potential of hydrogen (pH)&#xD;
3-hydroxy-3-methyl-glutaryl-CoA reductase&#xD;
Mevalonate&#xD;
Procalcitonin</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Hypnotherapy</condition>
  <arm_group>
    <arm_group_label>Hypnotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No Hypnotherapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hypnotherapy</intervention_name>
    <description>Pre- (one session) and postoperative (two sessions) Hypnotherapy</description>
    <arm_group_label>Hypnotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 years and older&#xD;
&#xD;
          -  Patients scheduled for open heart surgery or spinal column surgery&#xD;
&#xD;
          -  Offered patient information and written informed consent&#xD;
&#xD;
          -  Mini Mental State &gt; 23&#xD;
&#xD;
          -  American Society of Anesthesiologists physical status classification system (ASA) 1-3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No informed consent&#xD;
&#xD;
          -  Patients aged &lt;18 years&#xD;
&#xD;
          -  Patients living outside Berlin/Potsdam and surrounding area&#xD;
&#xD;
          -  Less than 5 points in Stanford Scale of Hypnotic Susceptibility: Form C; German&#xD;
             version (SHSS:C -Weitzenhoffer &amp; Hilgard, 1962; Bongartz, 1999 a)in the&#xD;
             screening/recruiting phase&#xD;
&#xD;
          -  Lacking consent capability or accommodation in an institution due to an official or&#xD;
             judicial order&#xD;
&#xD;
          -  Emergency patients or ambulant patients&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
&#xD;
          -  Coworkers at Charité&#xD;
&#xD;
          -  Lacking willingness to save and hand out data within the study&#xD;
&#xD;
          -  Insufficient knowledge of the German language&#xD;
&#xD;
          -  Participation in another trial according to the German Drug Law the week before&#xD;
             inclusion (in the study) and the parallel participation in another trial according to&#xD;
             the German Drug Law within the first 3 months after surgery&#xD;
&#xD;
          -  Acute, severe psychic disease (acute psychotic disorder, severe drug dependency,&#xD;
             withdrawal symptoms)&#xD;
&#xD;
          -  Conditions which make a sufficient information and consequent consent impossible&#xD;
&#xD;
          -  The patient is under juridical supervision&#xD;
&#xD;
          -  acute risk of suicide&#xD;
&#xD;
          -  dementia&#xD;
&#xD;
          -  patients who suffer from insulin dependent Diabetes mellitus and who have been&#xD;
             diagnosed with Diabetes mellitus within the last year&#xD;
&#xD;
          -  patients who have suffered allergic shock in the past&#xD;
&#xD;
          -  hardness of hearing, deafness, blindness&#xD;
&#xD;
          -  cardiac function: ejection fraction (EF) &lt; 30%&#xD;
&#xD;
          -  Patients undergoing psychotherapeutic treatment&#xD;
&#xD;
          -  Patients taking awareness-modulating drugs (antipsychotic drugs)&#xD;
&#xD;
          -  Boozed/primed patients or patients under drug influence&#xD;
&#xD;
          -  Patients having had an epileptic seizure within the last four weeks&#xD;
&#xD;
          -  Patients suffering from productive cough&#xD;
&#xD;
          -  Patients having a chronic low blood pressure (systolic &lt;90mmHg)&#xD;
&#xD;
          -  Allergies to any ingredient of the electrode fixing material (only for participants of&#xD;
             sleep stage assessment)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudia Spies, MD Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anaesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum (CVK) and Campus Charite Mitte (CCM), Charite - Universitätsmedizin Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum (CVK) and Campus Charite Mitte (CCM), Charite - Universitätsmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>January 30, 2012</study_first_submitted>
  <study_first_submitted_qc>January 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2012</study_first_posted>
  <last_update_submitted>August 9, 2016</last_update_submitted>
  <last_update_submitted_qc>August 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Claudia Spies</investigator_full_name>
    <investigator_title>Prof., MD Director of the Department of Anaesthesiology and Intensive Care Medicine CVK/CCM</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

